References
Original article
Choueiri, T. K. et al. Overall survival with adjuvant pembrolizumab in renal-cell carcinoma. N. Engl. J. Med. 390, 1359–1371 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Adjuvant pembrolizumab improves overall survival in patients with RCC. Nat Rev Clin Oncol (2024). https://doi.org/10.1038/s41571-024-00901-2
Published:
DOI: https://doi.org/10.1038/s41571-024-00901-2
- Springer Nature Limited